Cardiff Oncology, Inc. ( CRDF) - Stock Earnings
CRDF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -11.3 million USD | 120000 USD |
| 2025Q4 | -7.2 million USD | 243000 USD |
| 2026Q1 | -12.4 million USD | 41000 USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CRDF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -41.4 million USD | 488000 USD |
| 2024 | -45.4 million USD | 683000 USD |
| 2025 | -45.9 million USD | 593000 USD |
| 2026 Est. | — | — |
CRDF
Price: $1.40
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.67 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 531000
Market Capitalization: 120.3 million